Michael W. Bonney
Chairman
Alnylam Pharmaceuticals, Inc. (ALNY)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Michael W. Bonney
Michael W. Bonney is recorded as Chairman at Alnylam Pharmaceuticals, Inc. (ALNY). Alnylam Pharmaceuticals, Inc. reported in an 8-K filed December 3, 2025 that Michael W. Bonney resigned as director of the Board of Directors, effective December 2, 2025.
“On December 2, 2025, Michael W. Bonney and Carolyn Bertozzi, Ph.D. provided notice of each of their resignations from the Board of Directors (the “Board”) of Alnylam Pharmaceuticals, Inc. (the “Company”), effective on the same date.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2021-08-02–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Alnylam Pharmaceuticals, Inc.
Other people whose current roles at this company are on record from its filings.
- Yvonne Greenstreet CEO, COO
- Yvonne L. Greenstreet CEO, COO, Board Member
- Amy W. Schulman Chairman, Board Member
- Michael Bonney Chairman
- Jeffrey Poulton CFO
- Manmeet S CFO
- Akshay K. Vaishnaw, M.D., Ph.D. CIO
- Benjamin F. Cravatt Board Member
- Benjamin F. Cravatt, Ph.D. Board Member
- Carolyn R. Bertozzi Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.